95 related articles for article (PubMed ID: 8346593)
1. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL; Strandgaard S; Leyssac PP
Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
[TBL] [Abstract][Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
Esaian AM; Kaiukov IG; Titova VA
Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
[TBL] [Abstract][Full Text] [Related]
4. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
Kamper AL; Strandgaard S; Leyssac PP
Nephrol Dial Transplant; 1995; 10(7):1182-8. PubMed ID: 7478121
[TBL] [Abstract][Full Text] [Related]
5. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.
Kamper AL; Strandgaard S; Leyssac PP
Am J Hypertens; 1992 Jul; 5(7):423-30. PubMed ID: 1637513
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V; Lumlertgul D
J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
[TBL] [Abstract][Full Text] [Related]
9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
10. Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy.
Kamper AL; Thomsen HS; Nielsen SL; Strandgaard S
Scand J Urol Nephrol; 1990; 24(1):69-73. PubMed ID: 2157277
[TBL] [Abstract][Full Text] [Related]
11. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
[TBL] [Abstract][Full Text] [Related]
12. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
[TBL] [Abstract][Full Text] [Related]
13. Long-term enalapril treatment in diabetic nephropathy.
Mulec H; Johnsen SA; Björck S
Kidney Int Suppl; 1994 Feb; 45():S141-4. PubMed ID: 8158883
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
15. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
16. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
Kamper AL; Holstein-Rathlou NH; Leyssac PP; Strandgaard S
Am J Kidney Dis; 1996 Dec; 28(6):822-31. PubMed ID: 8957033
[TBL] [Abstract][Full Text] [Related]
17. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
18. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
Elung-Jensen T; Heisterberg J; Sonne J; Strandgaard S; Kamper AL
Eur J Clin Pharmacol; 2005 Apr; 61(2):87-96. PubMed ID: 15761754
[TBL] [Abstract][Full Text] [Related]
19. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
20. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
